Brain-immune interactions in arthritis: An integrated systems approach

Arthritis and Rheumatism

Volumn 58, Issue 10, 2008, Pages 2928-2930

  Jessop, David S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; SEMAPHORIN 3C; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ARTHRITIS; BRAIN FUNCTION; CHRONIC INFLAMMATION; CYTOKINE RELEASE; DISEASE SEVERITY; EDITORIAL; EXPERIMENTAL MODEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADRENERGIC FIBERS; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; HUMANS; INFLAMMATION; JOINTS; NEUROIMMUNOMODULATION; RATS;

EID: 54949153710     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23862     Document Type: Editorial

References (17)

1. Besedovsky HO, del Rey A. Physiology of psychoneuroimmunology: a personal view [review]. Brain Behav Immun 2007;21:34-44.
2. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007) [review]. Brain Behav Immun 2007;21:736-45.
3. Jessop DS. Neuropeptides: modulators of immune responses in health and disease [review]. Int Rev Neurobiol 2002;52:67-91.
4. Tanriverdi F, Silveira LF, MacColl GS, Bouloux PM. The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity [review]. J Endocrinol 2003;176:293-304.
5. Del Rey A, Wolff C, Wildmann J, Randolf A, Hahnel A, Besedovsky HO, et al. Disrupted brain-immune system-joint communication during experimental arthritis. Arthritis Rheum 2008;58:3090-9.
6. Miller LE, Weidler C, Falk W, Angele P, Schaumburger J, Scholmerich J, et al. Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2004;50:1156-63.
7. Mulla A, Buckingham JC. Regulation of the hypothalamo-pituitary-adrenal axis by cytokines [review]. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:503-21.
8. Harbuz MS. Neuroendocrinology of autoimmunity [review]. Int Rev Neurobiol 2002;52:133-61.
9. Jessop DS, Harbuz MS. A defect in cortisol production in rheumatoid arthritis: why are we still looking? [review]. Rheumatology (Oxford) 2005;44:1097-100.
10. Jessop DS, Richards LJ, Harbuz MS. Effects of stress on inflammatory autoimmune disease: destructive or protective? [review]. Stress 2004;7:261-6.
11. Dowdell KC, Gienapp IE, Stuckman S, Wardrop RM, Whitacre CC. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis. J Neuroimmunol 1999;100:243-51.
12. Gosselin D, Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system [review]. Brain Behav Immun 2007;21:281-9.
13. Roche M, Diamond M, Kelly JP, Finn DP. In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids. J Neuroimmunol 2006;181:57-67.
14. Leonard JP, MacKenzie FJ, Patel HA, Cuzner ML. Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain Behav Immun 1991;5:328-38.
15. Harle P, Mobius D, Carr DJ, Scholmerich J, Straub RH. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum 2005;52:1305-13.
16. Harbuz MS, Marti O, Lightman SL, Jessop DS. Alteration of central serotonin modifies onset and severity of adjuvant-induced arthritis in the rat. Br J Rheumatol 1998;37:1077-83.
17. Straub RH, Gunzler C, Miller LE, Cutolo M, Scholmerich J, Schill S. Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002;16:993-1000.